Market Research Logo

Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023

Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023

“Global vaccines market projected to grow at a CAGR of 6.7%”
The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing company initiatives to enhance R&D are driving the growth of the vaccines market. On the other hand, market growth may be hindered due to the high cost of vaccine development.

“Monovalent vaccines segment expected to hold the largest share of the market in 2018.”
Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment is expected to dominate this market with the largest share due to increasing investments by companies to develop new vaccines.

“Pneumococcal disease segment is expected to hold largest share of the market in 2018”
Based on the disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, herpes zoster, dengue, and other disease indications. The pneumococcal segment is expected to account for the largest share of the vaccines market in 2018. The large share of this segment can primarily be attributed to increasing government investments in pneumococcal vaccination programs and high incidence of pneumococcal diseases.

“Asia to witness high growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 36%; Tier 2 - 41%; Tier 3 - 23%.
By Designation (Supply Side): C-level - 25%; D-level - 29%; Others - 46%.
By Designation (Demand Side): General Physicians - 38%; Purchase Managers - 29%; Medical Researchers - 33%.
By Region: North America - 40%; Europe - 20%; Asia - 33%; RoW - 7%.

List of companies profiled in the report
GlaxoSmithKline plc (US)
Pfizer, Inc. (US)
Merck & Co., Inc. (US)
Sanofi Pasteur SA (France)
CSL Limited (Australia)
Emergent BioSolutions, Inc. (US)
Johnson & Johnson (US)
MedImmune, LLC (US)
Astellas Pharma Inc. (Japan)
Serum Institute of India (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo Company, Limited (Japan)
Biological E (India)
Panacea Biotec (India)

Research Coverage:
The report provides an overview of the vaccines market. It aims at estimating the market size and future growth potential of this market across different segments such as technology, type, disease indication, route of administration, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall vaccines market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKET COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DESIGN
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • OVERVIEW OF THE VACCINES MARKET
    • VACCINES MARKET, BY TYPE, 2018-2023
    • VACCINES MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
    • GEOGRAPHIC ANALYSIS: VACCINES MARKET, BY TECHNOLOGY
    • VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018 VS. 2023 (USD BILLION)
    • GEOGRAPHICAL SNAPSHOT OF THE VACCINES MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCIDENCE OF DISEASES
        • Table NIH FUNDING FOR VACCINE RESEARCH, 2013-2018 (USD MILLION)
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
        • Table IMMUNIZATION COVERAGE, BY DISEASE, 2015 VS 2016
  • INDUSTRY INSIGHTS
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
        • Table REGULATORY AUTHORITIES IN EUROPE
      • ASIA
        • Table REGULATORY AUTHORITIES IN ASIA
      • ROW
    • KEY PIPELINE PRODUCTS
      • Table KEY PIPELINE VACCINES
    • NEW VACCINE OPPORTUNITIES
      • HIV
        • Table ESTIMATED INVESTMENTS IN HIV VACCINES, BY INVESTOR (2015-2016)
      • MALARIA
      • ZIKA
      • EBOLA
        • Table EBOLA PROJECTS FUNDED BY EC (2014-2020)
  • VACCINES MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • CONJUGATE VACCINES
      • Table COST OF MENINGOCOCCAL CONJUGATE VACCINES
      • Table CONJUGATE VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • INACTIVATED AND SUBUNIT VACCINES
      • Table EXAMPLES OF INACTIVATED AND SUBUNIT VACCINES
      • Table INACTIVATED AND SUBUNIT VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • LIVE ATTENUATED VACCINES
      • Table LIVE ATTENUATED VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • RECOMBINANT VACCINES
      • Table EXAMPLES OF RECOMBINANT VACCINES
      • Table RECOMBINANT VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • TOXOID VACCINES
      • Table TOXOID VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • VACCINES MARKET, BY TYPE
    • INTRODUCTION
      • Table VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
    • MONOVALENT VACCINES
      • Table MONOVALENT VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • MULTIVALENT VACCINES
      • Table EXAMPLES OF NOTABLE MULTIVALENT VACCINES AVAILABLE IN THE MARKET
      • Table MULTIVALENT VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • VACCINES MARKET, BY DISEASE INDICATION
    • INTRODUCTION
      • Table VACCINES MARKET, BY DISEASE INDICATION, 2016-2023 (USD MILLION)
    • PNEUMOCOCCAL DISEASE
      • Table LIST OF COMMERCIALLY AVAILABLE PNEUMOCOCCAL VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR PNEUMOCOCCAL DISEASE, BY REGION, 2016-2023 (USD MILLION)
    • DTP
      • Table LIST OF COMMERCIALLY AVAILABLE DTP VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR DTP, BY REGION, 2016-2023 (USD MILLION)
    • INFLUENZA
      • Table LIST OF COMMERCIALLY AVAILABLE INFLUENZA VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR INFLUENZA, BY REGION, 2016-2023 (USD MILLION)
    • HPV
      • Table LIST OF COMMERCIALLY AVAILABLE HPV VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR HPV, BY REGION, 2016-2023 (USD MILLION)
    • MENINGOCOCCAL DISEASE
      • Table LIST OF COMMERCIALLY AVAILABLE HPV VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR MENINGOCOCCAL DISEASE, BY REGION, 2016-2023 (USD MILLION)
    • POLIO
      • Table LIST OF COMMERCIALLY AVAILABLE POLIO VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR POLIO, BY REGION, 2016-2023 (USD MILLION)
    • ROTAVIRUS
      • Table LIST OF COMMERCIALLY AVAILABLE ROTAVIRUS VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR ROTAVIRUS, BY REGION, 2016-2023 (USD MILLION)
    • HEPATITIS
      • Table LIST OF COMMERCIALLY AVAILABLE HEPATITIS VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR HEPATITIS, BY REGION, 2016-2023 (USD MILLION)
    • MMR
      • Table LIST OF COMMERCIALLY AVAILABLE MMR VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR MMR, BY REGION, 2016-2023 (USD MILLION)
    • VARICELLA
      • Table LIST OF COMMERCIALLY AVAILABLE VARICELLA VACCINES IN THE MARKET
      • Table VACCINES MARKET FOR VARICELLA, BY REGION, 2016-2023 (USD MILLION)
    • DENGUE
    • HERPES ZOSTER
      • Table VACCINES MARKET FOR HERPES ZOSTER, BY REGION, 2016-2023 (USD MILLION)
    • OTHER DISEASE INDICATIONS
      • Table LIST OF COMMERCIALLY AVAILABLE VACCINES FOR OTHER DISEASE INDICATIONS IN THE MARKET
      • Table VACCINES MARKET FOR OTHER DISEASE INDICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • VACCINES MARKET, BY ROUTE OF ADMINISTRATION
    • INTRODUCTION
      • Table VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
    • INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION
      • Table VACCINES MARKET FOR INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION, BY REGION, 2016- 2023 (USD MILLION)
    • ORAL ADMINISTRATION
      • Table VACCINES MARKET FOR ORAL ADMINISTRATION, BY REGION, 2016-2023 (USD MILLION)
    • OTHER ROUTES OF ADMINISTRATION
      • Table VACCINES MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY REGION, 2016-2023 (USD MILLION)
  • VACCINES MARKET, BY PATIENT TYPE
    • INTRODUCTION
      • Table VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
    • PEDIATRIC PATIENTS
      • Table VACCINES MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2016-2023 (USD MILLION)
    • ADULT PATIENTS
      • Table VACCINES MARKET FOR ADULT PATIENTS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2016-2023 (USD MILLION)
  • VACCINES MARKET, BY REGION
    • INTRODUCTION
      • Table VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: VACCINES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • US
        • Table US: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table US: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CANADA: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: VACCINES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table EUROPE: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: VACCINES MARKET, BY DISEASE INDICATION, 2016-2023 (USD MILLION)
      • Table EUROPE: VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
      • Table EUROPE: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • UK
        • Table UK: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • ITALY
        • Table ITALY: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • SPAIN
        • Table SPAIN: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • ROE
        • Table ROE: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • ASIA
      • Table ASIA: HEALTH EXPENDITURE PER CAPITA, BY COUNTRY, 2000, 2014 & 2016 (USD)
      • Table ASIA: VACCINES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ASIA: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA: VACCINES MARKET, BY DISEASE INDICATION, 2016-2023 (USD MILLION)
      • Table ASIA: VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
      • Table ASIA: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • CHINA
        • Table CHINA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • INDIA
        • Table INDIA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • REST OF ASIA (ROA)
        • Table ROA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: VACCINES MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table ROW: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ROW: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: VACCINES MARKET, 2016-2023 (USD MILLION)
      • Table ROW: VACCINES MARKET, 2016-2023 (USD MILLION)
      • Table ROW: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • LATIN AMERICA
        • Table LATIN AMERICA: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table LATIN AMERICA: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table LATIN AMERICA: VACCINES MARKET, BY DISEASE INDICATION, 2016-2023 (USD MILLION)
        • Table LATIN AMERICA: VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
        • Table LATIN AMERICA: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
      • OTHER ROW COUNTRIES
        • Table OTHER ROW COUNTRIES: VACCINES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table OTHER ROW COUNTRIES: VACCINES MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table OTHER ROW COUNTRIES: VACCINES MARKET, BY DISEASE INDICATION, 2016-2023 (USD MILLION)
        • Table OTHER ROW COUNTRIES: VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
        • Table OTHER ROW COUNTRIES: VACCINES MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
      • PRODUCT LAUNCHES AND APPROVALS
      • ACQUISITIONS
      • EXPANSIONS
  • COMPANY PROFILES
    • PFIZER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • GLAXOSMITHKLINE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • MERCK
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • SANOFI PASTEUR
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • CSL LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • EMERGENT BIOSOLUTIONS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • MEDIMMUNE, LLC (A SUBSIDIARY OF ASTRAZENECA)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • ASTELLAS PHARMA
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • SERUM INSTITUTE OF INDIA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • BAVARIAN NORDIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • MITSUBISHI TANABE PHARMA CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • DAIICHI SANKYO COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • PANACEA BIOTEC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
    • BIOLOGICAL E
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2015-2018)
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report